Jeevan Scientific Technology Ltd

Jeevan Scientific Technology has shown improved financial stability in its latest quarter, with operating cash flow reaching Rs 10.07 crore. However, challenges persist, including a decline in profit after tax and low inventory and debtors turnover ratios. The company has outperformed the Sensex in recent market performance.

Jeevan Scientific Technology Ltd., a clinical contract research organisation, reported a consolidated net loss of ₹0.09 crores in Q2 FY26, marking a dramatic reversal from the ₹0.24 crores profit recorded in the same quarter last year. The micro-cap healthcare services company, with a market capitalisation of ₹98.17 crores, saw its stock trade at ₹62.00 following the results, reflecting a modest 0.26% gain as investors grappled with the company's persistent profitability challenges despite a sequential improvement in revenue.

Jeevan Scientific Technology, a microcap in healthcare services, has recently experienced a Golden Cross, signaling potential bullish momentum. Despite a one-day decline, the stock has surged 69.91% over the past month, outperforming the Sensex. However, its three-year performance shows a decline, contrasting with the Sensex's growth.

Jeevan Scientific Technology Ltd is experiencing notable selling pressure, with the stock declining significantly over recent days. Despite a strong monthly performance, the company has underperformed compared to the Sensex, raising concerns about the factors driving the current downturn and indicating a challenging environment ahead.

Jeevan Scientific Technology achieved a new 52-week high of Rs. 66.9 on October 23, 2025, demonstrating strong performance in the healthcare services sector. The microcap company has consistently traded above key moving averages and delivered a 14.17% return over the past year, outperforming the Sensex.

Jeevan Scientific Technology Ltd is experiencing significant selling pressure, with today's trading showing only sellers. After a strong performance, the stock has declined, raising concerns about market sentiment. Despite recent gains, its longer-term performance has been mixed, underperforming the Sensex over the last three years.

Jeevan Scientific Technology Ltd is experiencing notable buying activity, with the stock achieving a new 52-week high and significant gains over the past week and month. The stock has shown consistent upward momentum, outperforming the broader market and benefiting from trends in the healthcare services sector.

Jeevan Scientific Technology has achieved a new 52-week high of Rs. 66.89, reflecting strong performance in the healthcare services sector. The stock has gained for 13 consecutive days, with a notable 93.16% return during this period, significantly outperforming the Sensex over the past year.

Jeevan Scientific Technology Ltd is experiencing notable buying activity, significantly outperforming the Sensex in the healthcare services sector. The stock has achieved consecutive gains over the past 12 days, reaching a new 52-week high and demonstrating strong performance across various time frames, indicating robust market interest.

Jeevan Scientific Technology has achieved a new 52-week high of Rs. 63.72, reflecting strong market performance. The healthcare microcap has gained for 12 consecutive days, with an impressive return of 86.97%. It is trading above key moving averages, showcasing a bullish trend and outperforming the Sensex significantly over the past year.

Jeevan Scientific Technology has achieved a new 52-week high of Rs. 61.84, reflecting strong performance in the healthcare services sector. The stock has surged 78.97% over the past 11 days and has consistently outperformed its sector, indicating a robust upward trend and solid market position.